Creo Medical Limited (LON:CREO) Insider Charles Spicer Buys 15,435 Shares of Stock

Creo Medical Limited (LON:CREOGet Rating) insider Charles Spicer acquired 15,435 shares of the firm’s stock in a transaction on Thursday, May 26th. The shares were acquired at an average price of GBX 97 ($1.22) per share, with a total value of £14,971.95 ($18,839.75).

Shares of LON CREO opened at GBX 97.50 ($1.23) on Friday. Creo Medical Limited has a one year low of GBX 94 ($1.18) and a one year high of GBX 220 ($2.77). The firm has a market capitalization of £176.48 million and a PE ratio of -7.22. The company has a current ratio of 2.52, a quick ratio of 2.17 and a debt-to-equity ratio of 20.53. The business has a 50-day moving average price of GBX 105.03 and a two-hundred day moving average price of GBX 127.32.

Creo Medical Company Profile (Get Rating)

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues.

Further Reading

Want More Great Investing Ideas?

Receive News & Ratings for Creo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical and related companies with's FREE daily email newsletter.